Flowers Kirsten
- SEC CIK
- 0001797209
No open-market purchases or sales filed in the past year.
Current role at each company
- PMVP PMV Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- CMRA Comera Life Sciences Holdings, Inc.Directoras of Nov 14, 2023
- KURA Kura Oncology, Inc.CCO & Chief Strategy Officeras of Jan 31, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Flowers Kirsten as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMRA Comera Life Sciences Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing)5:27 PM ET | Jan 4 | 41 days | Flowers KirstenDirector | PPurchase | +13.5K | $1.23 | +$16.6K | +155.6%22.2K after | Amended |
| Feb 14, 2023 (view filing)5:27 PM ET | Jan 4 | 41 days | Flowers KirstenDirector | PPurchase | +27.0K | $0.125 | +$3.38K | –13.5K after | AmendedDerivative |
KURA Kura Oncology, Inc.
CCO & Chief Strategy Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Flowers KirstenCCO & Chief Strategy Officer | SSale | −1.91K | $13.89 | −$26.5K | −8.5%20.6K after |